|
1
|
Chen W, Zheng R, Zhang S, Zeng H, Xia C,
Zuo T, Yang Z, Zou X and He J: Cancer incidence and mortality in
China, 2013. Cancer Lett. 401:63–71. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Choe J, Braschi-Amirfarzan M, Tirumani SH,
Shinagare AB, Kim KW, Ramaiya NH and Krajewski KM: Updates for the
radiologist in non-muscle-invasive, muscle-invasive, and metastatic
bladder cancer. Abdom Radiol (NY). 42:2710–2724. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lobo N, Mount C, Omar K, Nair R,
Thurairaja R and Khan MS: Landmarks in the treatment of
muscle-invasive bladder cancer. Nat Rev Urol. 14:565–574. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Hermans TJN, Voskuilen CS, van der Heijden
MS, Schmitz-Dräger BJ, Kassouf W, Seiler R, Kamat AM, Grivas P,
Kiltie AE, Black PC and van Rhijn BWG: Neoadjuvant treatment for
muscle-invasive bladder cancer: The past, the present, and the
future. Urol Oncol. Nov 8–2017.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Korpics MC, Block AM, Martin B, Hentz C,
Gaynor ER, Henry E, Harkenrider MM and Solanki AA: Concurrent
chemotherapy is associated with improved survival in elderly
patients with bladder cancer undergoing radiotherapy. Cancer.
123:3524–3531. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kang Z, Li Y, Yu Y and Guo Z: Research
progress on bladder cancer molecular genetics. J Cancer Res Ther.
10 Suppl:C89–C94. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Na SW, Yu SH, Kim KH, Hwang EC, Jung SI,
Kwon DD and Kang TW: The prognosis of patients less than 40 years
with bladder cancer. J Cancer Res Ther. 10:710–714. 2014.PubMed/NCBI
|
|
9
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bartel DP: MicroRNA Target recognition and
regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Liu A, Feng X, Tian L, Bo W, Wang
H and Hu Y: MiR-132 promotes the proliferation, invasion and
migration of human pancreatic carcinoma by inhibition of the tumor
suppressor gene PTEN. Prog Biophys Mol Biol. Sep 20–2017.(Epub
ahead of print). View Article : Google Scholar :
|
|
12
|
Slabakova E, Culig Z, Remsik J and Soucek
K: Alternative mechanisms of miR-34a regulation in cancer. Cell
Death Dis. 8:e31002017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhou Q, Huang SX, Zhang F, Li SJ, Liu C,
Xi YY, Wang L, Wang X, He QQ, Sun CC and Li DJ: MicroRNAs: A novel
potential biomarker for diagnosis and therapy in patients with
non-small cell lung cancer. Cell Prolif. 50:2017.doi:
10.1111/cpr.12394. View Article : Google Scholar
|
|
14
|
Jena MK: MicroRNAs in the development and
neoplasia of the mammary gland. Version 2. F1000Res. 6:10182017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Celano M, Rosignolo F, Maggisano V, Pecce
V, Iannone M, Russo D and Bulotta S: MicroRNAs as biomarkers in
thyroid carcinoma. Int J Genomics. 2017:64965702017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Masuda T, Hayashi N, Kuroda Y, Ito S,
Eguchi H and Mimori K: MicroRNAs as biomarkers in colorectal
cancer. Cancers (Basel). 9:1242017. View Article : Google Scholar :
|
|
17
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-145 downregulates SIP1-expression but
differentially regulates proliferation, migration, invasion and Wnt
signaling in SW480 and SW620 cells. J Cell Biochem. 119:2022–2035.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chen GM, Zheng AJ, Cai J and Han P:
microRNA-145-3p inhibits non-small cell lung cancer cell migration
and invasion by targeting PDK1 via the mTOR signaling pathway. J
Cellular Biochem. 119:885–895. 2018. View Article : Google Scholar
|
|
19
|
Setua S, Khan S, Doxtater K, Yallapu MM,
Jaggi M and Chauhan SC: miR-145: Revival of a dragon in pancreatic
cancer. J Nat Sci. 3:pii:e3322017.
|
|
20
|
Moon S, Kim DK and Kim J:
Apoptosis-related microRNA-145-5p enhances the effects of
pheophorbide a-based photodynamic therapy in oral cancer.
Oncotarget. 8:35184–35192. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chou CH, Chang NW, Shrestha S, Hsu SD, Lin
YL, Lee WH, Yang CD, Hong HC, Wei TY, Tu SJ, et al: miRTarBase
2016: Updates to the experimentally validated miRNA-target
interactions database. Nucleic Acids Res. 44:D239–D247. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Rieger-Christ KM, Lee P, Zagha R,
Kosakowski M, Moinzadeh A, Stoffel J, Ben-Ze'ev A, Libertino JA and
Summerhayes IC: Novel expression of N-cadherin elicits in vitro
bladder cell invasion via the Akt signaling pathway. Oncogene.
23:4745–4753. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bajan S and Hutvagner G: Regulation of
miRNA processing and miRNA mediated gene repression in cancer.
Microrna. 3:10–17. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wozniak M, Mielczarek A and Czyz M: miRNAs
in melanoma: Tumor suppressors and oncogenes with prognostic
potential. Curr Med Chem. 23:3136–3153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Tutar Y, Özgur A, Tutar E, Tutar L,
Pulliero A and Izzotti A: Regulation of oncogenic genes by
MicroRNAs and pseudogenes in human lung cancer. Biomed
Pharmacother. 83:1182–1190. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Zhang Z, Zhang M, Chen Q and Zhang Q:
Downregulation of microRNA-145 promotes epithelial-mesenchymal
transition via regulating Snail in osteosarcoma. Cancer Gene Ther.
24:83–88. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Sheng N, Tan G, You W, Chen H, Gong J,
Chen D, Zhang H and Wang Z: MiR-145 inhibits human colorectal
cancer cell migration and invasion via PAK4-dependent pathway.
Cancer Med. 6:1331–1340. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Zhou X, Yue Y, Wang R, Gong B and Duan Z:
MicroRNA-145 inhibits tumorigenesis and invasion of cervical cancer
stem cells. Int J Oncol. 50:853–862. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Li Y, Liu J, Liu ZZ and Wei WB:
MicroRNA-145 inhibits tumour growth and metastasis in osteosarcoma
by targeting cyclin-dependent kinase, CDK6. Eur Rev Med Pharmacol
Sci. 20:5117–5125. 2016.PubMed/NCBI
|
|
31
|
Sathyanarayanan A, Chandrasekaran KS and
Karunagaran D: microRNA-145 modulates epithelial-mesenchymal
transition and suppresses proliferation, migration and invasion by
targeting SIP1 in human cervical cancer cells. Cell Oncol (Dordr).
40:119–131. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang JH, Du AL, Wang L, Wang XY, Gao JH
and Wang TY: Episomal lentiviral Vector-mediated miR-145
overexpression inhibits proliferation and induces apoptosis of
human esophageal carcinomas cells. Recent Pat Anticancer Drug
Discov. 11:453–460. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiang Y, Zhang Y, Tang Y and Li Q: MALAT1
modulates TGF-β1-induced Endothelial-to-mesenchymal transition
through downregulation of miR-145. Cell Physiol Biochem.
42:357–372. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zeng JF, Ma XQ, Wang LP and Wang W:
MicroRNA-145 exerts tumor-suppressive and chemo-resistance lowering
effects by targeting CD44 in gastric cancer. World J Gastroenterol.
23:2337–2345. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hecht JR: Metastasis in colorectal cancer:
What makes the tumor aggressive? Eur J Surg Suppl. 104–110.
1998.PubMed/NCBI
|
|
36
|
Ellenrieder V, Adler G and Gress TM:
Invasion and metastasis in pancreatic cancer. Ann Oncol. 10 Suppl
4:S46–S50. 1999. View Article : Google Scholar
|
|
37
|
Singh M, Darcy KM, Brady WE, Clubwala R,
Weber Z, Rittenbach JV, Akalin A, Whitney CW, Zaino R, Ramirez NC
and Leslie KK: Cadherins, catenins and cell cycle regulators:
Impact on survival in a Gynecologic Oncology Group phase II
endometrial cancer trial. Gynecol Oncol. 123:320–328. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Derycke LD and Bracke ME: N-cadherin in
the spotlight of cell-cell adhesion, differentiation,
embryogenesis, invasion and signalling. Int J Dev Biol. 48:463–476.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Mariotti A, Perotti A, Sessa C and Ruegg
C: N-cadherin as a therapeutic target in cancer. Expert Opin
Investig Drugs. 16:451–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wu HM, Huang HY, Schally AV, Chao A, Chou
HH, Leung PC and Wang HS: Growth hormone-releasing hormone
antagonist inhibits the invasiveness of human endometrial cancer
cells by down-regulating twist and N-cadherin expression.
Oncotarget. 8:4410–4421. 2017.PubMed/NCBI
|
|
41
|
Da C, Wu K, Yue C, Bai P, Wang R, Wang G,
Zhao M, Lv Y and Hou P: N-cadherin promotes thyroid tumorigenesis
through modulating major signaling pathways. Oncotarget.
8:8131–8142. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wu X, Wang H, Lian Y, Chen L, Gu L, Wang J
and Huang Y, Deng M, Gao Z and Huang Y: GTSE1 promotes cell
migration and invasion by regulating EMT in hepatocellular
carcinoma and is associated with poor prognosis. Sci Rep.
7:51292017. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Abufaraj M, Haitel A, Moschini M, Gust K,
Foerster B, Özsoy M, D'Andrea D, Karakiewicz PI, Rouprêt M,
Briganti A and Shariat SF: Prognostic role of N-cadherin expression
in patients with invasive bladder cancer. Clin Genitourin Cancer.
Aug 15–2017.(Epub ahead of print).
|
|
44
|
Mo D, Yang D, Xiao X, Sun R, Huang L and
Xu J: MiRNA-145 suppresses lung adenocarcinoma cell invasion and
migration by targeting N-cadherin. Biotechnol Lett. 39:701–710.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Merchant N, Nagaraju GP, Rajitha B,
Lammata S, Jella KK, Buchwald ZS, Lakka SS and Ali AN: Matrix
metalloproteinases: Their functional role in lung cancer.
Carcinogenesis. 38:766–780. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Han YH, Kee JY, Kim DS, Mun JG, Park SH,
Kim YJ, Um JY and Hong SH: Arctii fructus inhibits colorectal
cancer cell proliferation and MMPs mediated invasion via AMPK. Am J
Chin Med. 45:1309–1325. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Lyu ZK, Li CL, Jin Y, Liu YZ, Zhang X,
Zhang F, Ning LN, Liang ES, Ma M, Gao W, et al: Paeonol exerts
potential activities to inhibit the growth, migration and invasion
of human gastric cancer BGC823 cells via downregulating MMP-2 and
MMP-9. Mol Med Rep. 16:7513–7519. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Chen W, Zhu H, Yin L, Wang T, Wu J, Xu J,
Tao H, Liu J and He X: lncRNA-PVT1 facilitates invasion through
upregulation of MMP9 in nonsmall cell lung cancer cell. DNA Cell
Biol. 36:787–793. 2017.PubMed/NCBI
|
|
49
|
Suyama K, Shapiro I, Guttman M and Hazan
RB: A signaling pathway leading to metastasis is controlled by
N-cadherin and the FGF receptor. Cancer Cell. 2:301–314. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Gao P, Xing AY, Zhou GY, Zhang TG, Zhang
JP, Gao C, Li H and Shi DB: The molecular mechanism of microRNA-145
to suppress invasion-metastasis cascade in gastric cancer.
Oncogene. 32:491–501. 2013. View Article : Google Scholar : PubMed/NCBI
|
